Tricida: There Is Further Upside

|
About: Tricida, Inc. (TCDA)
by: Avisol Capital Partners
This article is exclusive for subscribers.
Avisol Capital Partners
Long/short equity, newsletter provider, healthcare, biotech
Summary

Tricida is up nearly 100% since we recommended it in January 2019.

Since then, the PDUFA date has been announced - August 22, 2020.

We explore whether there is further upside to this recommended stock.

In January 2019, we recommended Tricida (TCDA) when it was trading near $21; after seeing positive results in an extension study to its pivotal phase 3 trial, the stock has now nearly doubled.